Table 4Study data for sustained headache response at 24 hours

StudyActive TreatmentComparator 1Comparator 2Active treatmentComparator 1Comparator 2
NNRNNRNNR
Brandes 2007A i 105,106TriptanNSAIDTriptan + NSAID127362107356174364
Brandes 2007A ii 105,106TriptanNSAIDTriptan + NSAID121362102264158362
Diener 2002A 217,219TriptanErgot-19141955201--
Freitag 2008A 287,291TriptanParacetamolTriptan + Paracetamol234318433048
Smith 2005742,743TriptanNSAIDTriptan + NSAID6622662248115250
798TriptanErgot-144266104266--

N; number of events, NR; number randomised

From: Appendix I, Network meta-analysis of pharmacological interventions for the acute treatment of migraine

Cover of Headaches
Headaches: Diagnosis and Management of Headaches in Young People and Adults [Internet].
NICE Clinical Guidelines, No. 150.
National Clinical Guideline Centre (UK).
Copyright © 2012, National Clinical Guideline Centre.

Apart from any fair dealing for the purposes of research or private study, criticism or review, as permitted under the Copyright, Designs and Patents Act, 1988, no part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

The rights of National Clinical Guideline Centre to be identified as Author of this work have been asserted by them in accordance with the Copyright, Designs and Patents Act, 1988.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.